Elkfork Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$7.48M Buy
51,831
+15,365
+42% +$2.24M 0.18% 107
2019
Q2
$5.42M Buy
36,466
+11,959
+49% +$1.67M 0.13% 150
2019
Q1
$3.22M Buy
24,507
+8,451
+53% +$1.04M 0.08% 206
2018
Q4
$1.74M Sell
16,056
-333
-2% -$44.6K 0.05% 262
2018
Q3
$2.45M Buy
16,389
+230
+1% +$35K 0.06% 248
2018
Q2
$2.49M Buy
16,159
+3,995
+33% +$603K 0.06% 239
2018
Q1
$1.69M Sell
12,164
-128
-1% -$18.8K 0.05% 252
2017
Q4
$1.69M Buy
12,292
+640
+5% +$84.6K 0.05% 274
2017
Q3
$1.51M Sell
11,652
-3,124
-21% -$417K 0.04% 274
2017
Q2
$1.96M Sell
14,776
-282
-2% -$34.5K 0.06% 230
2017
Q1
$1.86M Buy
15,058
+359
+2% +$42.5K 0.06% 244
2016
Q4
$1.62M Buy
+14,699
New +$1.63M 0.05% 242

Other funds holding LH

Elkfork Partners's LH Position: Q3 2019 in Review

Elkfork Partners increased its Labcorp (LH) stake by 42% in Q3 2019, buying an estimated $2.24M and bringing the position to 51,831 shares worth $7.48M. The position accounts for 0.18% of the portfolio, ranked #107.

Elkfork Partners first reported a position in LH in Q4 2016 and has held it in 12 quarters since. 739 funds tracked by Wall St. Rank hold LH as of Q3 2019.

  • Elkfork Partners held 51,831 shares of Labcorp worth $7.48M as of Q3 2019.
  • Elkfork Partners bought 15,365 Labcorp shares in Q3 2019, an estimated $2.24M.
  • Labcorp made up 0.18% of Elkfork Partners's portfolio in Q3 2019, its #107 holding.
  • Elkfork Partners first reported a position in Labcorp in Q4 2016 and has held it in 12 quarters since.
  • 739 funds tracked by Wall St. Rank held Labcorp as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.